Great way to end BCAM, @margenthalerj has always looked for ways to help her patients based in science. Love her perspective on DCISionRT! Knowledge is power.
We have data. Let’s use it to personalize DCIS care.
Julie Margenthaler, MD, @margenthalerj of Washington University in St. Louis joins Hannah Storm to discuss DCISionRT® data and radiation decisions—calling its impact “transformative for my practice.”
Full interview: bit.ly/47G8DZ1
#DCIS #DCISionRT
Amy Baker retweeted
Personalized care only makes a difference when patients can access it.
Join us Oct. 1 for Coverage at a Crossroads, a virtual Congressional briefing on personalized breast cancer testing—and why we must protect Medicare access to these important tools.
Register today. Join the conversation. Make a difference: bit.ly/4cxGjL4
Amy Baker retweeted
“I’m the Jalen Hurts when it comes to patient care.”
Breast surgeon Dr. Beth Dupree at Redeemer Health sees herself as the quarterback—helping patients understand their options and choose the best play.
See why @drbethdupree calls DCISionRT® “practice-changing.”
🎥Watch the full conversation: bit.ly/4hdvTSi
#DCIS #BreastCancer #DCISionRT
Amy Baker retweeted
Looking to see if DCISionRT is in your area? Our website shows where physicians are who order our test.
Enter your zip code, check out the map, then click on the link to contact our team—we will send you the information! bit.ly/4jYoDKh
#DCIS #DCISionRT
Amy Baker retweeted
"I want information about thiscancer—not somebody else's cancer." — Dr. Janie Grumley
Not every patient with DCIS benefits from radiation. Hear why Dr. Grumley calls DCISionRT® "life-changing"and how personalized information can help guide more confident treatment decisions.
🎥 Watch the full interview bit.ly/4hDOhFS
#DCIS #BreastCancer
Great DCIS discussion. Shared, informed decision making for the win!!
"It's about giving the right treatment at the right time to the right patient."
Radiation oncologist @DrRakeshPatel explains why shared decision-making matters —and why every woman deserves personalized information like DCISionRT to help guide her treatment.
🎥Click here to watch: bit.ly/4xjg0jC
#DCIS #BreastCancer
Amy Baker retweeted
"Radiation therapy can be very effective—but it's not necessary for everyone."
In Episode 4 of #ConversationsWithHannahStorm, breast surgeon Dr. Barry Rosen explains why personalized treatment is changing DCIS care and why he calls DCISionRT® "transformative."
🎥Watch now. bit.ly/4b8HpfG
#DCIS #PrecisionMedicine #DCISionRT
Tune in for more great DCIS discussions. @DrLaurenKopicky gives great insights and education.
Fear shouldn't drive treatment decisions.
In Part 3 of Conversations with Hannah Storm, Dr. Lauren Kopicky shares how DCISionRT® helps replace fear with personalized information—giving women with DCIS greater confidence in their treatment decisions.
🎥 Watch the full interview. bit.ly/4vuRKtL
#DCIS #BreastCancer
Amy Baker retweeted
NBC News just broke an important story: Medicare may reverse coverage for DCISionRT, a genomic test that helps women with Stage Zero breast cancer (DCIS) know whether they'll actually benefit from radiation.
The decision is expected July 17. It hits Medicare beneficiaries directly, and private insurers tend to follow Medicare's lead, so millions more women could lose access to this kind of personalized care.
I didn't learn about this test until after my own radiation treatment for DCIS. Once I saw what it could have told me, I started telling everyone I could, which led me to partner with @PreludeDx , the makers of DCISionRT, as a patient advocate.
Grateful to NBC News and reporter Gretchen Morgenson for this reporting.
Cancer patients deserve coverage for the most advanced tests available.
Watch: nbcnews.com/video/millions-m…
Read (subscription required): nbcnews.com/news/us-news/mil…
Great discussion on understanding risk and empowering patients.
DCISionRT helps facilitate difficult treatment discussions.
At ASBrS, Dr. Peled @annepeledmd shares her perspective on navigating a DCIS diagnosis—as both a breast surgeon and breast cancer survivor.
"It's a challenging conversation."
See how personalized insights from DCISionRT help inform treatment decisions.
Click here: bit.ly/4eFoCuG
Amy Baker retweeted
Part 1 of our Conversations with Hannah Storm series.
“You have Stage 0 Cancer… I’ve got you covered.”
Dr. Allison DiPasquale of Texas Breast Specialists discusses how informed conversations and genomic insights can help personalize DCIS treatment decisions.
Watch the full ASBrS interview: bit.ly/4y1ShWy
#DCIS #DCISionRT #ASBrS
Amy Baker retweeted
Proud to be featured in the Orange County Business Journal.
The story highlights PreludeDx's growth, AidaBreast®, and our commitment to advancing personalized breast cancer care.
Read more: bit.ly/4eODuGY
Exciting news!!!
Proud to be featured in the Orange County Business Journal.
The story highlights PreludeDx's growth, AidaBreast®, and our commitment to advancing personalized breast cancer care.
Read more: bit.ly/4eODuGY
Amy Baker retweeted
Breast fellows, join us for a BFU webinar on June 18 at 8 PM ET: Billing and Coding You Need to Know for Practice.
Exclusive to breast fellows. ASBrS members are automatically registered and should have received a Zoom confirmation by email.
breastsurgeons.org/education…
Amy Baker retweeted
Holly was diagnosed with DCIS in early 2026. A few days after receiving her DCISionRT score of 0.8, she sat down to share her story with us.
Read it here: bit.ly/4tXaMYJ
#DCISionRT #DCIS #PreludeDx
Amy Baker retweeted
Thank you to everyone who connected with the PreludeDx team at the #ASBrS2026 Annual Meeting last week in Seattle from our booth with Hannah Storm to AidaBREAST discussions, APP breakouts on DCISionRT, Grunge Fest, and every moment in between.
Amy Baker retweeted
Through advanced care and participation in radiation treatment learned from a groundbreaking clinical trial led by Dr. @AsalRahimiMD and other breast cancer researchers, Pam Minick continues to overcome challenges while helping change the future of care.
bit.ly/4w96HTM
Amy Baker retweeted
Honored to be included in the inaugural class of Fellows of the ASBrS (FASBrS) recognizing service to the society @ASBrS along with other amazing individuals many of whom I have had the pleasure to work with.
Honoring Truly Giants of breast surgical oncology selected to be the inaugural class of #FASBrS fellows of @ASBrS #ASBrS2026 @SBoolbol @DrJudyBoughey @DrJDietz @stevenchenmd @HenryKuerer @margenthalerj #deannaattai @beitsch @WhitworthMD @nemtipi @Ermanmd
Looking forward to all the new relationships and customers from #ASBrS2026.
Thank you to everyone who connected with us at #ASBrS2026 in Seattle. We left energized by meaningful conversations around DCIS care, AidaBreast® for early-stage invasive disease, and more personalized, evidence-driven treatment decisions. The conversation continues! #DCISionRT
